Abagovomab is a murine IgG1 monoclonal anti-idiotype antibody that functionally imitates the tumor-associated antigen, CA-125. Abagovomab has been used in the research of ovarian cancer treatment.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.